glutathione iv liver detox Therapy for Disease Efficacy of glutathione for the

The study identified 5-Amino-1MQ from a series of 1-methylquinolinium analogues through PAMPA and Caco-2 permeability screening and confirmed its high selectivity for NNMT over related SAM-dependent methyltransferases

Typical Clinical Ranges Loading Phase: 25 mg per week (subcutaneous injection) for 46 weeks Maintenance Phase: 2 mg every 12 weeks after the loading period Key Considerations Personalization: Dosage should be adjusted based on individual symptoms, sensitivities, and treatment response

High doses may cause temporary headaches due to increased NAD+ turnover and mitochondrial activity

10.1038/nn0103-5 233 PascualG.FongA